Systems Biology of Vaccinology

M13

Course Goals 

Definition and overview of the systems biology approach; examples of systems biology studies in immunology and vaccine studies; learn how to perform transcriptomic data analysis and correlation analysis with immunologic data.

Timeline 

Application Deadline:
Postponed*

​Course Dates:
Q1 2022 (2 days)

Organiser

University of Siena,
Siena, Italy

Participant Nr.: max. 15

Contact

Francesco Santoro santorof@unisi.it

Course content

Day 1 will be dedicated to lectures on systems biology in general and to more specific application in the immunology and vaccine fields.

Day 2 will alternate lectures with an hands-on analysis of transcriptomic data.

Learning Outcomes

Participants will build a solid theoretical background on systems biology and will learn how to approach transcriptomic data.

Who should apply

PhD students, postdocs and senior scientists interested in the systems biology approach applied to vaccine studies.

Minimal requirements

The course is mainly aimed at early career researcher (PhD students and post-docs) with an immunological background, but is open to scientists at any level and with different backgrounds. Although not compulsory, some confidence with R or other programming languages would be preferred (a basic R introduction can be found at https://r4ds.had.co.nz/index.html). Participants should bring their own laptop for the practical part.

Accommodation

The whole course will be held in the “Certosa di Pontignano” (https://www.lacertosadipontignano.com/it/index.php) a medieval cloister just outside Siena. Accommodation (two nights) and meals are included. Travel costs are not included.

Comments

* Due to COVID19 related delays call and training modules' schedule may be subject to change.
Be the first to know about the upcoming application calls, follow European Vaccine Initiative on Twitter and LinkedIn or subscribe to TRANSVAC Newsletter.

Weblink

Back to Training Modules

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Subscribe to TRANSVAC´s Mailing list

© 2021 European Vaccine Initiative. Designed by European Vaccine Initiative